Even though her eyes were clouded with cataracts, Mrs. Romero’s gaze was steady, leaving no room for ambiguity. No room for argument. “I won’t take insulin,” she said firmly, “I don’t care if I die.” Period. End of discussion. At 85-years-of-age, my patient was joining the ranks of a new movement: elderly patients who refuse to take medications ordered by their doctors.
Isolated incidents or the cusp of a new trend? Just how big is…
Read more »
A new regulatory debate about whether certain medications should require prescriptions makes me reflect on how good things used to be when it comes to obtaining my own diabetes meds over-the-counter.
Insulin, in particular.
Two decades ago when I was on second-generation insulin like Regular and Lente, I could walk into a pharmacy and pick up a bottle of insulin without needing a prescription. That was helpful during those times when I forgot my insulin…
Read more »
According to the American Diabetes Association, seven million people have undiagnosed type 2 diabetes, and a staggering 79 million more have pre-diabetes. Early detection of type 2 diabetes can save lives, which is what drives the ADA’s recent Diabetes Alert Day. But Dr. Michael Snyder, a geneticist at Stanford University, has taken early detection to a whole new level.
Dr. Snyder and his team have spent the last three years of their lives years working…
Read more »
By
WilD on
December 31, 2011
Maybe it’s your stomach gone awry, or maybe you’re just totally confused about which dietary supplements actually matter… either way, we’ve got you covered.
We answer all sorts of diabetes-related queries here at Ask D’Mine, our weekly advice column hosted by community educator and author Wil Dubois (also a veteran T1 PWD).
{Need help navigating life with diabetes? AskDMine@diabetesmine.com}
Lisa from Nevada, type 1 writes: I’m trying to get my head around which vitamins…
Read more »
It’s not too often we have a new insulin making its way on the scene, so we were excited to hear that Novo Nordisk filed two applications with the FDA for a new “ultra long acting” insulin called Degludec, and another for something called DegludecPlus, a combination of degludec and insulin aspart (Novolog), which would be available in an insulin pen in a fixed 70% degludec/30% Novolog ratio. The company is hoping for FDA approval…
Read more »
